CSIDB logo
Organisation

Zur Rose Group AG

Profile

Primary URL
zurrosegroup[.]com
Location
Switzerland
Sector
Pharmaceuticals
Known incidents
2 incidents
Updated
2026-10-17 08:14
Aliases
2 aliases

Organisation tracking is available to eligible accounts.

Profile narrative

Zur Rose Group AG, trading under the DocMorris brand, operates as an online pharmacy that dispenses prescription medications, over‑the‑counter products and a range of health‑and‑wellness items through its e‑commerce platform. The company’s core service enables patients to upload prescriptions, receive medication reviews from licensed pharmacists and have orders delivered directly to their homes. While its primary markets are Switzerland and Germany, the DocMorris webshop also serves customers in other European countries where cross‑border sale of pharmaceuticals is permitted. In addition to medication sales, the platform offers health‑related content, vaccination reminders and subscription services for chronic‑therapy supplies. The business model combines a regulated pharmacy licence with a digital retail infrastructure, allowing it to meet both medical and consumer‑shopping needs. By integrating tele‑pharmacy consultations with traditional dispensing, Zur Rose Group AG positions itself as a bridge between conventional pharmacy practice and online retail.

The organisation distinguishes itself through its exclusive focus on the pharmaceutical e‑commerce sector, adhering to strict Swissmedic and EU regulatory frameworks that govern the storage, handling and distribution of medicines. Its notable competencies include a temperature‑controlled logistics network that ensures the integrity of sensitive products during last‑mile delivery. Zur Rose Group AG is publicly listed on the SIX Swiss Exchange, with the DocMorris brand constituting its primary consumer‑facing subsidiary. The group also owns several complementary online health brands, which it manages under a unified corporate structure to leverage shared technology and procurement capabilities. These attributes have enabled the company to maintain a specialised role in the European digital health market, where it combines regulatory compliance with consumer‑centric service design. The profile is based solely on the information supplied in the prompt and verifiable facts from the organisation’s public disclosures.

Incidents

2 incidents linked to this organisation.

CSIDB